Yongin, South Korea

Sung-Il Jeon

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Infopia Co., Ltd., Osang Healthcare Co., Ltd.. Active years: 2016-2018.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sung-Il Jeon in Biosensor Technology

Introduction

Sung-Il Jeon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biosensor technology, holding 2 patents that showcase his innovative approach to improving glucose analysis.

Latest Patents

His latest patents include a reagent composition for a biosensor that demonstrates high sensitivity. This invention is capable of enhancing the analysis linearity of analytes such as glucose by utilizing a combination of oxidoreductase, a metal-containing complex, and Naphthol Green B. The design minimizes the blood volume required for measuring blood glucose, allowing for the detection of small concentrations of the analyte. The reagent composition incorporates at least two types of electron transfer mediators, including Naphthol Green B, along with an enzyme, making it a significant advancement in biosensor technology.

Career Highlights

Sung-Il Jeon has worked with reputable companies such as Infopia Co., Ltd. and Osang Healthcare Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative biosensor solutions.

Collaborations

He has collaborated with notable coworkers, including Sung-Kwon Jung and Seung-Min Im, further enhancing his work in the field.

Conclusion

Sung-Il Jeon's contributions to biosensor technology reflect his dedication to innovation and improvement in medical diagnostics. His patents are a testament to his expertise and commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…